Soligenix to present at the q1 virtual investor summit

Princeton, n.j., march 2, 2022 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its senior vice president and chief financial officer, jonathan guarino, has been invited to attend the q1 virtual investor summit.
SNGX Ratings Summary
SNGX Quant Ranking